Angiotensin‐receptor blockers and diuretics—Advantages of combination

Abstract

Surveys have shown that in as many as half of patients treated for hypertension, blood pressure (BP) is not controlled to target levels; many more persons have undertreated hypertension. Uncontrolled hypertension is a serious risk factor for cardiovascular events such as stroke, heart failure, myocardial infarction and target‐organ disease. Studies have shown that strict BP control significantly reduces the occurrence of these cardiovascular outcomes; however, in the majority of patients, effective BP control requires two or more antihypertensive agents. The combination of an angiotensin‐receptor blocker (ARB) and a thiazide diuretic is appealing, since these agents have complimentary effects on BP reduction, left ventricular hypertrophy and progression of renal disease. In addition, this combination provides excellent tolerability. The combination of an ARB and a thiazide diuretic may be of particular value in patient populations who tend to have poor BP control on monotherapy, or have additional cardiovascular or renal risk factors.

• Angiotensin‐receptor blocker
• combination therapy
• diuretic
• hypertension
• populations